Another research showed that ADSCs-derived exosomes inhibited prostate cancer via delivery of miR-145 by promoting apoptosis through the caspase-3/7 pathway and reducing the activity of Bcl-xL (Takahara et al., 2016). Here, BCL2L1 is linked to prostate carcinoma.